Ishita Drugs & Industries Ltd.

ISHITADR

₹83.95

6.94% (5.45)

Market Cap

₹23 Cr.

P/E

27.26

About

Ishita Drugs & Industries Ltd is the flagship company of the 'Ishita' Group. They are engaged in the manufacture of various Active Pharma Ingredients (bulk actives and their salts), bulk drug interme… Read more

Ishita Drugs & Industries Ltd is the flagship company of the 'Ishita' Group. They are engaged… Read more

Low

52W Range

High

105

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Other Income

Other income component is making ratios of the company look optically better
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Ishita Drugs & Industries Ltd. Business

What does Ishita Drugs & Inds. do?

Ishita Drugs & Industries Ltd, a leading company of the 'Ishita' Group, specializes in manufacturing Active Pharma Ingredients, drug intermediates, excipients, and fine chemicals with a focus on quality and environmental safety.

Who are the competitors of Ishita Drugs & Inds.?

Ishita Drugs & Inds. major competitors are Adeshwar Meditex, Phaarmasia, Zenith Health Care, Kabra Drugs, Chemo Pharma Labs, Hamps Bio, Emmessar Biotech&Nut.
Market Cap of Ishita Drugs & Inds. is ₹23 Crs.
While the median market cap of its peers are ₹22 Crs.

Is Ishita Drugs & Inds. financially stable compared to its competitors?

Ishita Drugs & Inds. seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Ishita Drugs & Industries Ltd.

Ishita Drugs & Industries Ltd.

About

Timeline

Company Timeline

9 Yes

2 Neutral

5 No

1 No Data

Accounting & Shareholding

Depreciation Effect

Pledge

Retail Holding

Revenue Recognition

Promoter Holding

Other Income

Contingent Liabilities

Price & Performance

Capex vs ROCE

ROE

Share price

Working Capital

Debt

Balance Sheet Strength

Current vs Historic Valuation

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

What does Ishita Drugs & Inds. do?

Who are the competitors of Ishita Drugs & Inds.?

Is Ishita Drugs & Inds. financially stable compared to its competitors?

SIGN UP FOR FREE